Cardiometabolic Disorders News

SAN DIEGO — Children in an underserved community who increased the number of times per week they ate breakfast had lower fasting insulin and insulin resistance than those who ate breakfast less often, according to a speaker.

New-onset chronic kidney disease among U.S. adults with diabetes was highest among racial and ethnic minorities compared with white individuals, according to findings published in The New England Journal of Medicine.

CHICAGO — The dual SGLT inhibitor sotagliflozin reduced 30- and 90-day rates of CV mortality and HF-related events when administered before hospital discharge after an episode of worsening HF, according to new data from the SOLOIST trial.

Black adults in the United States with multiple cardiometabolic morbidities are at increased risk for both all-cause and CHD mortality, according to a study.

Levels of cholesterol, triglycerides and other serum components that indicate CVD risk increased for women in Japan who underwent menopause in the past 15 years, according to longitudinal data published in Menopause.

SAN DIEGO — Exercising at a consistent time may encourage adults with obesity to participate in regular moderate to vigorous physical activity, according to a speaker at ObesityWeek 2022.

SAN DIEGO — Weight loss can be achieved by people who exercise in either the morning or the evening, though findings on whether morning or evening physical activity is better for losing weight are mixed, according to a speaker.

CHICAGO — A meta-analysis of 13 large SGLT2 inhibitor trials, including the recently published EMPA-KIDNEY trial, indicates that the drug class reduces CV and renal outcomes across all high-risk groups, with and without type 2 diabetes.

CHICAGO — In the PROMINENT trial, pemafibrate lowered triglycerides but did not cut the incidence of CV events compared with placebo in patients with type 2 diabetes and mixed dyslipidemia.

Study results published in Diabetologia found no association between the number of daily sedentary time breaks and lower liver fat content or reduced insulin resistance.